APOE and Alzheimer disease: In Northern European Ancestry individuals, homozygous carriers of APOE ε4 have up to a 12-fold increased risk for AD compared to non-carriers, whereas there is a weaker but significant effect for incident AD in persons of Yoruba ancestry in Nigeria1,5–7.